Medicina cardiovascular

A continuación, se enumeran los ensayos clínicos actuales.

Filtra esta lista de estudios por sede, estatus, etc.

1. Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)

   Rochester, Minn.

   Fluoroscopy guided EMB and EAM guided EMB on all patients meeting existing guidelines for biopsy.

2. Genotype-Phenotype Correlation in Cardiovascular Disease

   Rochester, Minn.

   This research study is being done to help characterize cardiovascular disease and improve diagnostic tests.

   OBJECTIVES

   1. To understand the pathogenesis, molecular mechanisms, and disease progression of heritable cardiovascular disease

   2. To evaluate the incidence of occult heritable cardiovascular disease in various populations.

   3. To correlate imaging and pathological phenotype with genotype to the ends described above.

3. A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients with Mayo Stage IIIa AL Amyloidosis

   Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.

   The purpose of this study is to determine if CAEL-101 improves the overall survival in patients with cardiac AL Amyloidosis.

    

    

4. Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

   Rochester, Minn.

   The purpose of this study is to evaluate the safety and effectiveness of the WiSE-LV System for Cardiac Re-synchronization Therapy.

5. Investigation of Body's Changes in Human Health and Performance via Simulated Intermittent Altitude

   Rochester, Minn., Scottsdale/Phoenix, Ariz.

   The purpose of this study is obtain blood biomarkers, exercise performance measurements, and perceived experience to help optimize an intermittent altitude exposure protocol for individuals that perform exercise in high altitude.

6. A Study to Assess the Role of Biomarkers in Risk Stratification in Adults with Congenital Heart Disease

   Rochester, Minn.

   The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, and to  determine if temporal changes in biomarker levels can provide a better risk prediction compared to biomarker assay obtained at baseline.

7. Exercise during Heart Cath in CHD Patients

   Rochester, Minn.

   The purpose of this study is to compare the difference in the ability to detect blood flow abnormalities between invasive assessments performed at rest versus exercise.

8. A Study of Aortic Valve Gradient Severity in Patients with Atrial Fibrillation

   Rochester, Minn.

   The purpose of this study is to examine if the measurements that we make by current standards for patients with both aortic stenosis (narrowed aortic valve) and atrial fibrillation underestimate severity of aortic stenosis and if that has any effect on timing of aortic valve surgery

    

9. Surveillance HeartCare® Outcomes Registry

   Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.

   The purpose of this study is to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

10. A Study to Evaluate the Adagio System to Treat Persistent Atrial Fibrillation

    Jacksonville, Fla.

    The purpose of this study is to provide safety and effectiveness data regarding the use of the Adagio System in the treatment of Persistent Atrial Fibrillation (PsAF).